SummaryKenvue, the maker of Tylenol, is pushing back against an FDA proposal to update its safety label with a potential link between acetaminophen use during pregnancy and autism or ADHD in children. The company cites decades of research supporting the drug’s safety, while the FDA and public petitions highlight ongoing debate and scrutiny over the issue.